The European market for obesity interventions will grow through 2024, driven by increasing bariatric surgery procedure volumes—which will positively impact the unit sales of internal closure devices—and by growth in the intragastric balloon segment, because of the introduction of new products that will gain adoption.
This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the obesity interventions market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.
- Obesity Interventions - Market Insights - Europe (Supplemental)
Author(s): Jason R Lau, MA
Jason Lau is the manager of the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, leading a team of analysts responsible for monitoring and analyzing global endovascular device markets. Jason has strong expertise in endoscopy and minimally invasive surgery device markets and extensive knowledge in the fields of gastroenterology, bariatrics, and urology; he has also participated and presented at industry leading conferences, including MD&M. Jason holds an Honors Bachelor's degree from the University of Toronto and a Master's degree in Psychology from New York University.